Literature DB >> 3949117

Rapid vesicle formation and aggregation in abnormal human biles. A time-lapse video-enhanced contrast microscopy study.

Z Halpern, M A Dudley, A Kibe, M P Lynn, A C Breuer, R T Holzbach.   

Abstract

Rapid nucleation of cholesterol crystals has previously been shown to provide a sharp discrimination between abnormal (cholesterol gallstone-associated) and normal human gallbladder bile. In the present study, we sought to further clarify the crystal nucleation process by time-lapse microscopy using a novel high-resolution video-enhanced microscopy technique. Using a previously described method for removal of particles from abnormal biles, we found a strikingly rapid rate of de novo formation of unilamellar vesicles, soon followed by massive vesicular aggregation, culminating in crystal formation. In normal biles, by contrast, this rapid aggregation process was not observed and the isolated unilamellar vesicles showed prolonged stability. Morphometric analysis of interval particle counts showed statistically significant differences. The process of cholesterol monohydrate crystal nucleation in supersaturated human bile is characterized by a sequential combination of vesicle formation, vesicle aggregation, and subsequent crystal formation. The primary distinction between abnormal and normal biles resides only in the consistent rapidity of onset and completion of these events in the abnormal biles.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3949117     DOI: 10.1016/0016-5085(86)90863-2

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  32 in total

1.  Gallbladder dysfunction enhances physical density but not biochemical metastability of biliary vesicles.

Authors:  Y Sunami; S Tazuma; G Kajiyama
Journal:  Dig Dis Sci       Date:  2000-12       Impact factor: 3.199

2.  Cryoelectron microscopy of a nucleating model bile in vitreous ice: formation of primordial vesicles.

Authors:  D L Gantz; D Q Wang; M C Carey; D M Small
Journal:  Biophys J       Date:  1999-03       Impact factor: 4.033

Review 3.  Cholesterol crystallisation in bile.

Authors:  P Portincasa; K J van Erpecum; G P Vanberge-Henegouwen
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

4.  Less hydrophobic phosphatidylcholine species simplify biliary vesicle morphology, but induce bile metastability with a broad spectrum of crystal forms.

Authors:  Minoru Sakomoto; Susumu Tazuma; Kazuaki Chayama
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

5.  Quantitative assessment of comparative potencies of cholesterol-crystal-promoting factors: relation to mechanistic characterization.

Authors:  T Nishioka; S Tazuma; G Yamashita; G Kajiyama
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

Review 6.  Update on the Molecular Mechanisms Underlying the Effect of Cholecystokinin and Cholecystokinin-1 Receptor on the Formation of Cholesterol Gallstones.

Authors:  Helen H Wang; Piero Portincasa; David Q-H Wang
Journal:  Curr Med Chem       Date:  2019       Impact factor: 4.530

7.  Effect of gallbladder hypomotility on cholesterol crystallization and growth in CCK-deficient mice.

Authors:  Helen H Wang; Piero Portincasa; Min Liu; Patrick Tso; Linda C Samuelson; David Q-H Wang
Journal:  Biochim Biophys Acta       Date:  2009-10-22

8.  Stabilization of biliary lipid particles by ursodeoxycholic acid. Prolonged nucleation time in human gallbladder bile.

Authors:  S Mizuno; S Tazuma; G Kajiyama
Journal:  Dig Dis Sci       Date:  1993-04       Impact factor: 3.199

9.  Distribution of cholesterol among its carriers in the bile of male and female hamsters.

Authors:  T Mikami; B I Cohen; Y Mikami; N Ayyad; E H Mosbach
Journal:  Lipids       Date:  1994-08       Impact factor: 1.880

10.  Measurement of apolipoprotein A1 in cholesterol gallstones and gallbladder bile of patients with gallstones.

Authors:  T Hasegawa; I Makino
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.